 Artist: Dakona: mp3 download Genre(s): Pop: Pop-Rock Dakona's discography:  Perfect Change Year: 2003 Tracks: 13 Dakona formed in the mid-'90s when Ryan McAllister and his cousin-german, John Biondolillo, teamed up with their friends Shane Dueck and Brook Winstanley. Spending their step down time rehearsing in an old b, Dakona played any gig they could get, including opening for a sex activity therapist, something that surprised McAllister. When he and the rest of Dakona showed up for the gig, they saw a microphone. Believing it was a minimalist band, they didn't think anything of it. When the sexuality healer hit the stage, Dakona found it amusing. Things went uphill from there. Dakona formed a unattackable following throughout Canada and circumferent perimeter towns. Their D.I.Y. make ethic paid off a class by and by when they released "Honorable Enough for Me" to honorable reviews. In 2000, they followed it up with "Ordinary Heroes." After sign language with Maverick, they agreed to ferment with producer Arnold David Lanni, best-known for his ferment with Our Lady Peace, one of McAllister's favorites. Dakona left the sessions early -- seeking to "acquire" as a band. Next, they landed in the studio of Grammy Award-winning manufacturer Rob Cavallo (Goo Goo Dolls). After 18 days in the studio, Dakona finished what would become Perfect Change. |
Wednesday, 10 September 2008
Mp3 music: Dakona
Monday, 1 September 2008
Download Esham mp3
 Artist: Esham: mp3 download Genre(s): Dance Rap: Hip-Hop Other Pop Discography:  Acid Rain Year: 2004 Tracks: 29  Repentance Year: 2003 Tracks: 20  KKKill the Fetus Year: 2000 Tracks: 21  Judgement Day Vol. 2 Year: 2000 Tracks: 15  Judgement Day Vol. 1 Year: 2000 Tracks: 16  Detroit Dogshit Year: 2000 Tracks: 19  Mail Dominance Year: 1999 Tracks: 22  Bruce Wayne: Gotham City 1987 Year: 1999 Tracks: 20  Dead Flowers Year: Tracks: 20  Closed Casket Year: Tracks: 21  Boomin Words From Hell Year: Tracks: 16  A1-Yola Year: Tracks: 17 As an underappreciated cult artist, Esham's harsh hard-core hip-hop thrived in this hometown of Detroit, MI, for long time forrader an corps de ballet of artists with a similar elan began crossing over into the mainstream in the late '90s. Long ahead rock candy acts of the Apostles such as Limp Bizkit began rapping, foresighted in advance rappers such as Kid Rock began rocking, Esham was integration a rock candy influence into his rap in the early '90s, crafting a unequalled style of self-declared "caustic rap." In fact, this term is rather accommodation, disposed Esham's mouthful for hallucinogenic rhymes revolving virtually paranoia, dying, drugs, sexual practice, and absolute evil -- an super decadent synthesis of all things hair-raising. Beyond his bent for rock-influence beat generation and exploitative-themed rhymes, Esham as well proved himself to be a fecund artist, releasing over an album a class after debuting with his number 1 album in 1990 at the crank age of 13. Yet despite his impressive certificate, by the remnant of the '90s, the Detroit knocker mum hadn't elongated his reach beyond his cult next, unlike other Detroit artists such as Eminem, Kid Rock, and ICP, and other similar hip-hop groups such as Three 6 Mafia and Brotha Lynch Hung. As a youth, Esham (natural Rashaam Smith) dual-lane his time between New York and Detroit, spending summers with his nanna in the hip-hop mecca participating in that culture's mid to late-'80s boom, while expenditure the remainder of the class with his mother in the grim, postindustrial, musical thaw potful of East Detroit. Given his involvement in New York's burgeoning late-'80s rap movement during his summers, it wasn't that out of the ordinary that he was authorship his have rhymes by the time he was ten-spot. Yet the fact that he self-released his debut album, Boomin' Words From Hell, three long time by and by in 1990 spell a high school newcomer was emphatically out of the ordinary. With his elder brother handling the line slope of the music, including the blood of Esham's own label, Reel Life Productions, the knocker concentrated on his rhymes. Furthermore, he as well happened to grow every thrum on his first record album in addition to busting every verse, a truly notable achievement granted his young age, especially considering the album's still-impressive caliber. After Boomin' Words From Hell, Esham churned stunned deuce immediate four-song EPs, Homey Don't Play That and Erotic Poetry, ahead returning in 1992 with an ambitious double album that found him furthering his origin into degeneracy. Titled Judgment Day and released in two individually sold volumes, the album showed the creative person having evolved too in price of rapping and production (victimisation a all-inclusive palette of stone samples ranging from Black Sabbath's "War Pigs" to Black Flag's "Arise Above"), in addition to his more atrocious subject matter. Furthermore, Esham likewise debuted his group project, NATAS (purportedly an acronym for Nation Ahead of Time and Space, sooner than "The Tempter" spelled backward as many presume). Also featuring fellow Detroit rappers Mastamind and TNT, NATAS' debut album, Life sentence After Death, was most as hard-core as Esham's solo material, though a bite more adult. In late 1992 came the Hellterskkkellter EP, which foreshadowed Esham's next album, 1993's KKKill the Fetus. That year too saw the vent of the second NATAS album, Blaz4me, followed by the Maggot Brain Theory EP and Unopen Casket, both released in 1994, and another NATAS album in 1995, Doubelievengod. With each album following the Judgment Day series, Esham's work had continued to evolve in terms of craft, with more and more meticulous product and better rapping. More significant, though, was the changes that took place in the beatniks and in the subject matter. Where Esham's former albums were soundscapes pieced together from rock samples and some lo-fi metal drum machines and bass guitar, his albums began to take on a more conventional production feel, exploitation less samples and more polished beatniks. In increase, his rhymes didn't get whatever less wicked -- noneffervescent preoccupied with degeneracy -- just they did turn less juvenile and more creative. By the clock time Dead Flowerz was released in 1996, Esham did evidence a move by from exploitive subject matter, though -- a change that divided his craze hearing. On the one hand, it made him more than accessible, and many acknowledged the fact that his lyrics relied less on exploitatory themes and more on creative thinking. Yet on the former hand, his traditionalist fans loathed the fact that Esham was easy drifting towards ceremonious themes, even if his euphony was up. The iI 1997 releases -- Bruce Wayne 1987 and NATAS' Multikillionaire -- confirmed the tendency, even if the albums had their share of worrisome moments. When Mail Dominance came out in 1999, Esham was distinctly a much different rapper than he had been eld earlier when he championed everything controversial. This album found him tackling ceremonious themes and egg laying down evenhandedly conventional beat generation (co-produced by Jade Scott [aka Santos]); yet it's authoritative to preserve in mind that Esham smooth gave his music a trademark twist and instilled his dark, wild attitude into music, proving that he didn't penury to bank on exploitation whatsoever yearner to impress listeners. His longtime friends had a difficult time accepting this, only when he returned with NATAS' WWW.Com in 2000, it was earn that Esham's calling was indeed moving to the succeeding story. On this album, he emphasised alive instrumentation in his beatniks, including a heavy utilization of bass guitars, which, of course of action, alluded to the rap-metal of acts such as Korn and a refreshed Kid Rock. It's likewise authoritative to eminence that Esham signed a distribution consider with TVT for his Overcore label (formerly Reel Life) earlier cathartic WWW.Com, a right business move that assuring calibre statistical distribution of his albums across America. To immortalise this new consider, Esham put together Bootleg: From the Lost Vault, Vol. 1, a compiling released in 2000 including a broad array of his former material along with a few new tracks for premature fans. That same yr, TVT distributed re-released versions of Detroit Dog Shit (some other digest originally released in 1997) and his former major solo albums. Following Eminem's major breakthrough in 2000 and the successive plug circumferent D-12, Esham's profile suddenly rose, and he positioned himself for a breakthrough of his possess in 2001. Just before releasing his long-awaited Tongues album, Overcore released Kool Keith's Spankmaster album, which featured considerable contributions by Esham. And with Keith also featured on Tongues, a new audience suddenly discovered the cultish Detroit rapper. Released in summer 2001, Tongues no dubiety stood as Esham's to the highest degree labored album to date, a 24-track epical featuring a blanket range of production styles and quick segues from one strain to the next, with few songs clocking all over four minutes. In an exertion to promote the album, the rapper embarked on the Warped circuit that summertime with Keith and made sure to conjure up a feud with Eminem. |
Friday, 22 August 2008
Peter Wolf and Kid Rock: A be-Geils-ing combination
Peter Wolf doesn�t know apart. Last week the early J. Geils Band frontman went low-spirited to Foxwoods� MGM Grand to ascertain Bob Dylan; last year he joined Bruce Springsteen onstage at the TD Banknorth Garden. But by spending a big chunk of this summer performing on Kid Rock�s Rock and Roll Revival Tour, Wolf proven he�ll pay heed with anyone.
Rock, in casing you haven�t noticed, is enjoying a career revivification. His album, �Rock N Roll Jesus,� was released nearly a year ago, but has spent the last few months close the top of the Billboard 200 on its way to passing the million mark in sales. His latest single, the well-timed �All Summer Long,� is now shooting up both the pop and country charts. To cover it off, critics ar no longer turning up their noses at Kid; they�re praising him for putting together one of the most diverse, entertaining and unexpected tours of the season.
Wolf isn�t scheduled to perform with Rock�s revue - which straightaway features Lynyrd Skynyrd and Reverend Run - at its Comcast Center occlusive on Saturday. But don�t be surprised if he does.
�With Kid Rock and myself,� Wolf said, �you ne'er can tell what�s passing to bump. So I could be there after all.�
Speaking by phone from backstage at the Dylan show, Wolf talked about why he and Kid make a great partner off and when we tush expect his long-overdue next solo album.
Herald: I remember most people consider you and Kid Rock an odd combination, yet you toured for several weeks together. Where�s the common ground?
Wolf: He comes from Detroit, and the Geils Band has very especial history with Detroit. This is how he knew me and why he asked me to bring together him. That city has a history of qualification special demands on its performers; non just anyone will do. When you break it down, the White Stripes, MC5, Iggy Pop and the Stooges, Bob Seger, all experience that live something that Geils too had. And Kid Rock�s got it, too.
So he can compete with those Detroit legends on stage?
Rock �n� turn over fans like rock �n� roll, and his approaching to hit the microscope stage is all rock �n� roll. He works hard and it shows. Yeah, he�s a great performer.
And off the stage?
(Laughs) He works strong and he plays severe. Being out on the road with Kid is like 24/7, nonstop, rock �n� roll Mardi Gras. No bars held, anything goes, all the time.
When you weigh that Run-DMC�s Reverend Run was also out on some dates with you guys, the idea of the tour really gets strange. Did the triplet of you get along? Did the audience get into having all these different genres thrown at them?
People were very responsive to all of it. Rev Run has special way of shaking it up out in that respect, and it�s cool because he represents a different aspect of Kid Rock�s musical personality. Between Rev Run and myself you have deuce of Kid Rock�s bountiful influences right-hand there with him. And, yeah, I enjoyed hanging out with both of them. It worked great.
You�re recording your first newfangled album in six old age in Boston and New York. Did your alliance with Kid Rock and Rev Run inspire you to institute in some odd collaborators for this album?
I�m working with some of my favorite musicians, and so you john expect some duets. I�m working with all these greats: Shelby Lynne, Merle Haggard, Neko Case. And of course some great locals, as well, like (guitarist) Duke Levine and (drummer) Marty Richards. If anyone�s been following (my) solo stuff, it�s on that continuum.
Kid Rock, with Rev Run and Lynyrd Skynyrd, at the Comcast Center, Mansfield, Saturday. Tickets: $20-$65; 508-339-2333.
More info
Tuesday, 12 August 2008
Merrimack Pharmaceuticals Initiates Enrollment In A Phase 1 Study Of MM-121, An ErbB3 Antagonist
�Merrimack Pharmaceuticals,
Inc. proclaimed that the first patient has standard an initial dose in
a Phase 1 clinical study of the Company's first oncology product, MM-121, a
fully human monoclonal antibody antibody and a first-in-class therapeutic designed
to block signaling of the ErbB3 receptor.
ErbB3 is a receptor in the ErbB family, a pathway that plays a critical
function in genus Cancer signaling. With the initiation of the Phase 1 trial, MM-121
becomes the first systems biology product as well as the first selective
ErbB3 antagonist to figure human clinical development.
"We used a combination of high-throughput biological science and computer
simulation to discern the importance of targeting ErbB3 signaling in tumor
cells," said Dr. Ulrik B. Nielsen, Senior Vice President of Research. "We
believe this is the first systems-designed therapeutical in clinical
development. Until now, figurer simulation has not been widely applied
toward understanding optimal curative strategies for treating cancers
driven by complex signaling pathways."
Preclinical data demonstrating the impact of MM-121 in multiple cancer
models were presented at the annual get together of the American Association for
Cancer Research in April. The Phase 1 dose escalation study will evaluate
the safety and pharmacokinetics (PK) of MM-121. Enrollment is underway at
Fox Chase Cancer Center and 2 additional leading oncology sites are
expected to participate in the trial subsequently this year.
"ErbB3 is now recognized as a potentially significant target in many
types of crab including lung, breast, colorectal, ovarian and others,"
aforementioned Dr. William J. Slichenmyer, Senior Vice President and Chief Medical
Officer at Merrimack. "Preclinical studies of MM-121 have demonstrated
antineoplastic activity in a wide-eyed range of tumor types and a very favorable
safety profile. We are optimistic that these findings may translate into
clinical benefit for patients wHO participate in the clinical trials. In
addition, we are very pleased to be on the job with in the lead clinical
investigators at undischarged academic cancer research centers."
Merrimack has developed a broad noetic property position around
its oncology therapeutic portfolio, including MM121. This portfolio
includes U.S. and international patent filings relating to compositions of
matter and methods of use as well as licensed patents and pending patent
applications, craft secrets and proprietary know-how.
About MM-121
MM-121 is a monoclonal antibody designed to block signaling of the
ErbB3 sensory receptor, a receptor in the ErbB family, a tract that plays a
critical role in cancer sign. Upon knowledgeability of the Phase 1 trial,
MM-121 becomes the first systems biology product as well as the first
selective ErbB3 antagonist to enter human clinical development. Preclinical
data exhibiting MM-121's shock on multiple cancer models (including lung,
ovarian, chest, prostate and renal) were presented at the yearbook meeting
of the American Association for Cancer Research in April 2008. The Phase 1
trial is being conducted at 3 centers in the United States.
About Merrimack
Merrimack Pharmaceuticals, Inc., is a biotechnology company focused on
the discovery, conception and ontogeny of novel treatments for diseases in
the areas of autoimmunity and cancer. Its autoimmune candidate, MM-093, is
presently in Phase 2 clinical development. Its first oncology product,
MM-121 is currently in Phase 1 clinical development. MM-093 and MM-121 are
investigational drugs and have not been approved by the U.S. Food and Drug
Administration or any international regulatory agency. The company's
proprietary Network Biology discovery platform, developed with the help of
leading scientists from MIT and Harvard, enables the high throughput
profiling of protein networks as a basis for improved validation, lead
identification and speed in the development of innovative therapeutics.
Merrimack is a privately-held company based in Cambridge, Massachusetts.
For additional information, please visit http://www.merrimackpharma.com.
Merrimack Pharmaceuticals, Inc.
http://www.merrimackpharma.com
More information
Inc. proclaimed that the first patient has standard an initial dose in
a Phase 1 clinical study of the Company's first oncology product, MM-121, a
fully human monoclonal antibody antibody and a first-in-class therapeutic designed
to block signaling of the ErbB3 receptor.
ErbB3 is a receptor in the ErbB family, a pathway that plays a critical
function in genus Cancer signaling. With the initiation of the Phase 1 trial, MM-121
becomes the first systems biology product as well as the first selective
ErbB3 antagonist to figure human clinical development.
"We used a combination of high-throughput biological science and computer
simulation to discern the importance of targeting ErbB3 signaling in tumor
cells," said Dr. Ulrik B. Nielsen, Senior Vice President of Research. "We
believe this is the first systems-designed therapeutical in clinical
development. Until now, figurer simulation has not been widely applied
toward understanding optimal curative strategies for treating cancers
driven by complex signaling pathways."
Preclinical data demonstrating the impact of MM-121 in multiple cancer
models were presented at the annual get together of the American Association for
Cancer Research in April. The Phase 1 dose escalation study will evaluate
the safety and pharmacokinetics (PK) of MM-121. Enrollment is underway at
Fox Chase Cancer Center and 2 additional leading oncology sites are
expected to participate in the trial subsequently this year.
"ErbB3 is now recognized as a potentially significant target in many
types of crab including lung, breast, colorectal, ovarian and others,"
aforementioned Dr. William J. Slichenmyer, Senior Vice President and Chief Medical
Officer at Merrimack. "Preclinical studies of MM-121 have demonstrated
antineoplastic activity in a wide-eyed range of tumor types and a very favorable
safety profile. We are optimistic that these findings may translate into
clinical benefit for patients wHO participate in the clinical trials. In
addition, we are very pleased to be on the job with in the lead clinical
investigators at undischarged academic cancer research centers."
Merrimack has developed a broad noetic property position around
its oncology therapeutic portfolio, including MM121. This portfolio
includes U.S. and international patent filings relating to compositions of
matter and methods of use as well as licensed patents and pending patent
applications, craft secrets and proprietary know-how.
About MM-121
MM-121 is a monoclonal antibody designed to block signaling of the
ErbB3 sensory receptor, a receptor in the ErbB family, a tract that plays a
critical role in cancer sign. Upon knowledgeability of the Phase 1 trial,
MM-121 becomes the first systems biology product as well as the first
selective ErbB3 antagonist to enter human clinical development. Preclinical
data exhibiting MM-121's shock on multiple cancer models (including lung,
ovarian, chest, prostate and renal) were presented at the yearbook meeting
of the American Association for Cancer Research in April 2008. The Phase 1
trial is being conducted at 3 centers in the United States.
About Merrimack
Merrimack Pharmaceuticals, Inc., is a biotechnology company focused on
the discovery, conception and ontogeny of novel treatments for diseases in
the areas of autoimmunity and cancer. Its autoimmune candidate, MM-093, is
presently in Phase 2 clinical development. Its first oncology product,
MM-121 is currently in Phase 1 clinical development. MM-093 and MM-121 are
investigational drugs and have not been approved by the U.S. Food and Drug
Administration or any international regulatory agency. The company's
proprietary Network Biology discovery platform, developed with the help of
leading scientists from MIT and Harvard, enables the high throughput
profiling of protein networks as a basis for improved validation, lead
identification and speed in the development of innovative therapeutics.
Merrimack is a privately-held company based in Cambridge, Massachusetts.
For additional information, please visit http://www.merrimackpharma.com.
Merrimack Pharmaceuticals, Inc.
http://www.merrimackpharma.com
More information
Wednesday, 6 August 2008
Nino Rota
Artist: Nino Rota
Genre(s):
Instrumental
Soundtrack
Vocal
Discography:
Grand Collection
Year: 2003
Tracks: 22
The Godfather Part Ii
Year: 1972
Tracks: 14
The Godfather
Year: 1972
Tracks: 12
Roma
Year: 1972
Tracks: 12
Waterloo
Year: 1970
Tracks: 9
Satyricon
Year: 1970
Tracks: 1
I Clowns
Year: 1970
Tracks: 2
Boccaccio 70
Year: 1970
Tracks: 15
Romeo and Juliet
Year: 1968
Tracks: 21
The Taming Of The Shrew
Year: 1967
Tracks: 20
Spara Forte Piu Forte Non Capi
Year: 1966
Tracks: 21
Il Giornalino Di Gian Burrasca
Year: 1965
Tracks: 28
Giulietta Degli Spiriti
Year: 1965
Tracks: 13
Leopard (Il Gattopardo)
Year: 1963
Tracks: 13
Il Maestro Di Vigevano
Year: 1963
Tracks: 4
8 1/2
Year: 1963
Tracks: 12
Rocco E I Suoi Fratelli
Year: 1960
Tracks: 12
La Dolce Vita
Year: 1960
Tracks: 11
La Grande Guerra
Year: 1959
Tracks: 12
La Diga Sul Pacifico
Year: 1958
Tracks: 11
Le Notti Di Cabiria
Year: 1957
Tracks: 15
Guerra E Pace
Year: 1956
Tracks: 12
Un Eroe Dei Nostri Tempi
Year: 1955
Tracks: 8
Il Bidone
Year: 1955
Tracks: 9
Accadde Al Penitenziario
Year: 1955
Tracks: 6
La Strada
Year: 1954
Tracks: 19
Fortunella
Year: 1953
Tracks: 13
Il Due Timidi (Opera)
Year: 1950
Tracks: 1
Famed for his elysian work with conductor Federico Fellini, Nino Rota was one of the to the highest degree fertile and acclaimed flick composers of his era, with a list of soundtrack credits ranging from La Dolce Vita to Franco Zeffirelli's Romeo and Juliet to Francis Ford Coppola's The Godfather. Born December 3, 1911 in Milan. Italy, Rota was a tiddler prodigy world Health Organization had already written an opera and an oratorio
Grizzly Park (2008) [Horror]
Tuesday, 24 June 2008
New Baron Cohen film for next year
'Bruno', Sacha Baron Cohen's planned follow-up to the hit comedy spoof movie 'Borat' has been scheduled for release on 15 May, 2009.
Like 'Borat', which tracked the misadventures of Baron Cohen's incompetent Kazakh documentary maker character, the new film, which is currently in production, is based on a comedy character played by Baron Cohen.
This time, 'Bruno', a gay Austrian fashion journalist who has appeared in Cohen's TV work, will be the lead and the film will follow his attempt to bring his chat show to America.
According to some reports, the new film may be titled: 'Bruno: Delicious Journeys Through America for the Purpose of Making Heterosexual Males Visibly Uncomfortable in the Presence of a Gay Foreigner in a Mesh T-Shirt'.
Like 'Borat', which tracked the misadventures of Baron Cohen's incompetent Kazakh documentary maker character, the new film, which is currently in production, is based on a comedy character played by Baron Cohen.
This time, 'Bruno', a gay Austrian fashion journalist who has appeared in Cohen's TV work, will be the lead and the film will follow his attempt to bring his chat show to America.
According to some reports, the new film may be titled: 'Bruno: Delicious Journeys Through America for the Purpose of Making Heterosexual Males Visibly Uncomfortable in the Presence of a Gay Foreigner in a Mesh T-Shirt'.
Sunday, 22 June 2008
Kate Hudson and Owen Wilson engaged?
Kate Hudson and Owen Wilson have reportedly got engaged after the 'Fool's Gold' and 'How To Lose A Guy in Ten Days' star was spotted wearing a diamond ring on her wedding finger last week.
Hollywood star Hudson was photographed wearing the ring outside a restaurant in Boston, sparking speculation that the on-off couple are poised to tie the knot.
The couple met on the set of 'You, Me and Dupree' in 2006 and were romantically linked later that year, after Hudson split from her husband of six years, Black Crowes star Chris Robinson.
However, Hudson and Wilson parted ways last June, just two months before Wilson's alleged suicide attempt. Rumours began to circulate that the end of their relationship was the reason behind the attempt on his life.
However, in recent months the couple have reunited and were spotted with Wilson's parents on Hudson's 29th birthday last month.
A source told the News Of The World: "Kate supported Owen during his low patch and that proved to him she's the woman he wants to be with for ever. The engagement is a natural step for them both."
Hollywood star Hudson was photographed wearing the ring outside a restaurant in Boston, sparking speculation that the on-off couple are poised to tie the knot.
The couple met on the set of 'You, Me and Dupree' in 2006 and were romantically linked later that year, after Hudson split from her husband of six years, Black Crowes star Chris Robinson.
However, Hudson and Wilson parted ways last June, just two months before Wilson's alleged suicide attempt. Rumours began to circulate that the end of their relationship was the reason behind the attempt on his life.
However, in recent months the couple have reunited and were spotted with Wilson's parents on Hudson's 29th birthday last month.
A source told the News Of The World: "Kate supported Owen during his low patch and that proved to him she's the woman he wants to be with for ever. The engagement is a natural step for them both."
Subscribe to:
Posts (Atom)